Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spalding, J. W.
Right arrow Articles by Tennant, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spalding, J. W.
Right arrow Articles by Tennant, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 53, 213-223 (2000)
Copyright © 2000 by the Society of Toxicology

Responses of Transgenic Mouse Lines p53+/- and Tg•AC to Agents Tested in Conventional Carcinogenicity Bioassays

Judson W. Spalding*,1, John E. French*, Stanley Stasiewicz*, Marianna Furedi-Machacek{dagger}, Fawn Conner{dagger}, Raymond R. Tice{dagger} and Raymond W. Tennant*

* National Institute of Environmental Health Sciences, Laboratory of Environmental Carcinogenesis and Mutagenesis, Research Triangle Park, North Carolina 27709; and {dagger} Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709

The haplo-insufficient p53 knockout (p53+/-) and zetaglobin v-Ha-ras (Tg•AC) transgenic mouse models were compared to the conventional two rodent species carcinogen bioassay by prospectively testing nine chemicals. Seven of the chemicals classified as carcinogens in the conventional bioassay induced tumors in the liver or kidneys of B6C3F1 mice, and one (pentachlorophenol) also induced tumors in other tissues. Only three chemicals, furfuryl alcohol, pyridine, and pentachlorophenol, induced tumors in rats. The tumorigenic effect of pyridine was seen in F344 rats but not in Wistar strain rats. None of the chemicals induced tumors in the p53+/- transgenic mice, which is consistent with the absence of genotoxicity of these chemicals. Only two of the seven nongenotoxic carcinogens were positive in the Tg•AC model (lauric acid diethanolamine and pentachlorophenol). These results show that these transgenic models do not respond to many chemicals that show strain- or species-specific responses in conventional bioassays.

Key Words: Tg•AC, p53+/-; transgenic; mouse bioassays; cancer..


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
D.G. Allen, G. Pearse, J.K. Haseman, and R.R. Maronpot
Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of Liver Tumors in NTP Carcinogenicity Studies
Toxicol Pathol, June 1, 2004; 32(4): 393 - 401.
[Abstract] [PDF]


Home page
Toxicol SciHome page
T. Takizawa, K. Mitsumori, T. Tamura, M. Nasu, M. Ueda, T. Imai, and M. Hirose
Hepatocellular Tumor Induction in Heterozygous p53-Deficient CBA Mice by a 26-Week Dietary Administration of Kojic Acid
Toxicol. Sci., June 1, 2003; 73(2): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice
Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. StJ. Battalora, J. W. Spalding, C. J. Szczesniak, J. E. Cape, R. J. Morris, C. S. Trempus, C. D. Bortner, B. M. Lee, and R. W. Tennant
Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse
Carcinogenesis, April 1, 2001; 22(4): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. French, R. D. Storer, and L. A. Donehower
The Nature of the Heterozygous Trp53 Knockout Model for Identifi cation of Mutagenic Carcinogens
Toxicol Pathol, January 1, 2001; 29(1_suppl): 24 - 29.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding
The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model
Toxicol Pathol, January 1, 2001; 29(1_suppl): 51 - 59.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
S. Venkatachalam, S. D. Tyner, C. R. Pickering, S. Boley, L. Recio, J. E. French, and L. A. Donehower
Is p53 Haploinsufficient for Tumor Suppression? Implications for the p53+/- Mouse Model in Carcinogenicity Testing
Toxicol Pathol, January 1, 2001; 29(1_suppl): 147 - 154.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
P. L. Carmichael, J. J. Mills, M. Campbell, M. Basu, and J. Caldwell
Mechanisms of Hormonal Carcinogenesis in the p53+/- Hemizygous Knockout Mouse: Studies With Diethylstilbestrol
Toxicol Pathol, January 1, 2001; 29(1_suppl): 155 - 160.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
J. I. Goodman
A Perspective on Current and Future Uses of Alternative Models for Carcinogenicity Testing
Toxicol Pathol, January 1, 2001; 29(1_suppl): 173 - 176.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
J. Ashby
Expectations for Transgenic Rodent Cancer Bioassay Models
Toxicol Pathol, January 1, 2001; 29(1_suppl): 177 - 182.
[Abstract] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
F. M. JOHNSON
The "Rodent Carcinogen" Dilemma: Formidable Challenge for the Technologies of the New Millennium
Ann. N.Y. Acad. Sci., September 1, 2000; 919(1): 288 - 299.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.